ID   K-562-B1-V-2 p17
AC   CVCL_LH52
DR   Wikidata; Q54899218
RX   PubMed=2446768;
RX   PubMed=2465826;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
RX   PubMed=2446768; DOI=10.1007/BF02797342;
RA   Walter H., Al-Romaihi F.A., Krob E.J., Seaman G.V.F.;
RT   "Fractionation of K-562 cells on the basis of their surface properties
RT   by partitioning in two-polymer aqueous-phase systems.";
RL   Cell Biophys. 10:217-232(1987).
//
RX   PubMed=2465826; DOI=10.1007/BF02918374;
RA   Walter H., Krob E.J., Al-Romaihi F.A., Johnson D., Lozzio C.B.;
RT   "Detection of surface differences between closely related cell
RT   populations by partitioning. Cultured K-562 cell sublines.";
RL   Cell Biophys. 13:173-187(1988).
//